AgingResearch.NewsJoin free

Platinum nanoparticles

Platinum nanoparticles has been studied in 2 papers since 2024: none in people yet, 1 in animals, 1 review; 1 in the past year. The research so far is in animals. The newest story, Oct 25, 2026: “Targeted RNA delivery alleviates bone loss in mice”.

Intervention

2 papers study itUpdated

1 new paper in 30 daysSee all 2

3 of its findings point the other way.

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

  • 2 independent labs
  • 3 findings against
  • Animals1

What did lifespan studies of Platinum nanoparticles find?

DrugAge

DrugAge records 6 results from 2 papers: 6 in C. elegans. Average lifespan is the mean or the median, as each paper reports it.

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
Materials Today Bio

Targeted RNA delivery alleviates bone loss in mice

In a mouse model of osteoporosis caused by ovary removal, bone-targeted engineered vesicles preserved bone structure and reduced bone-breakdown activity without causing…In a mouse model of osteoporosis caused by ovary removal, bone-targeted engineered vesicles preserved bone structure and reduced bone-breakdown activity without causing systemic toxicity.

Mouse studyBones and joints
Paper

Related